This is a Validated Antibody Database (VAD) review about human IL-10, based on 120 published articles (read how Labome selects the articles), using IL-10 antibody in all methods. It is aimed to help Labome visitors find the most suited IL-10 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IL-10 synonym: CSIF; GVHDS; IL-10; IL10A; TGIF

Invitrogen
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...
Invitrogen IL-10 antibody (eBioscience, 12-7108-82) was used in flow cytometry on human samples . J Immunother Cancer (2022) ncbi
rat monoclonal (JES3-12G8)
  • ELISA; human; 1:2000; fig 6d
Invitrogen IL-10 antibody (eBioscience, 13-7109-85) was used in ELISA on human samples at 1:2000 (fig 6d). Commun Biol (2022) ncbi
rat monoclonal (JES3-9D7)
  • ELISA; human; 1:2000; fig 6d
Invitrogen IL-10 antibody (eBioscience, 14-7108-85) was used in ELISA on human samples at 1:2000 (fig 6d). Commun Biol (2022) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig s4a
Invitrogen IL-10 antibody (eBioscience, 12-7108-81) was used in flow cytometry on human samples (fig s4a). Cell (2019) ncbi
rat monoclonal (JES3-9D7)
  • ELISA; human; loading ...; fig 5c
Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in ELISA on human samples (fig 5c). J Immunol (2018) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 4a
Invitrogen IL-10 antibody (ebioscience, 16-7108-85) was used in flow cytometry on human samples (fig 4a). Oncotarget (2018) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in flow cytometry on human samples (fig 3b). J Clin Invest (2018) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; rhesus macaque; fig 6f
  • flow cytometry; human; fig 1e
In order to identify and characterize CXCR5hiCD44hiCD8 T cells in HIV-infected individuals, Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in flow cytometry on rhesus macaque samples (fig 6f) and in flow cytometry on human samples (fig 1e). PLoS Pathog (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 6c
In order to report that IgA-producing plasma cells are a major source of inducible NO synthase in Helicobacter pylori-infected patients, Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in flow cytometry on human samples (fig 6c). J Immunol (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig s1
In order to show that ATG16L1 and NOD2 are required for Bacteroides fragilis-mediated protection from colitis, Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in flow cytometry on human samples (fig s1). Science (2016) ncbi
rat monoclonal (JES3-12G8)
  • immunohistochemistry - paraffin section; human; 1:100; fig 4
In order to assess modulation of cytokine expression in the intestine of patients with ulcerative colitis by bilberry-derived anthocyanins, Invitrogen IL-10 antibody (Thermo Fisher, JES3-12G8) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; African green monkey; loading ...; fig 5a
In order to report that B cells modulate the local granulomatous response in Mycobacterium tuberculosis-infected macaques during acute infection, Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in flow cytometry on African green monkey samples (fig 5a). Infect Immun (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig 6
Invitrogen IL-10 antibody (eBioscience, 48-7108) was used in flow cytometry on human samples (fig 6). Nat Commun (2015) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig 7
Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in flow cytometry on human samples (fig 7). Haematologica (2016) ncbi
mouse monoclonal (945A2A5)
  • immunohistochemistry - frozen section; human; 1:50; fig 2
In order to investigate factors that regulate delayed-type hypersensitivity, Invitrogen IL-10 antibody (Life Technologies, 945A2A5) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 2). F1000Res (2015) ncbi
mouse monoclonal (945A2A5)
  • immunohistochemistry - paraffin section; human
In order to elucidate the role of IL-10 in human papillomavirus infection, Invitrogen IL-10 antibody (Invitrogen, 945A2A5) was used in immunohistochemistry - paraffin section on human samples . Immunology (2015) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
Invitrogen IL-10 antibody (Ebioscience, JES3-9D7) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (945A5A10)
  • ELISA; South American squirrel monkey
Invitrogen IL-10 antibody (Biosource, 945A5A10) was used in ELISA on South American squirrel monkey samples . Malar J (2015) ncbi
mouse monoclonal (945A5D11)
  • ELISA; South American squirrel monkey
Invitrogen IL-10 antibody (Biosource, 945A5D11) was used in ELISA on South American squirrel monkey samples . Malar J (2015) ncbi
rat monoclonal (JES3-9D7)
  • immunocytochemistry; human
Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in immunocytochemistry on human samples . Autoimmun Rev (2015) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in flow cytometry on human samples . Hum Immunol (2014) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in flow cytometry on human samples . Chest (2015) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
In order to evaluate immune responses by monocyte isolated from young and old adults before and after influenza vaccination, Invitrogen IL-10 antibody (Affymetrix eBioscience, JES3?C9D7) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human; 20 ug/ml
Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in blocking or activating experiments on human samples at 20 ug/ml. Immunology (2014) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; African green monkey; 10 ug/ml; fig s4
In order to decipher how susequent acute infection is supressed in T cell responses after exposure to subinfectious hepatitis C virus, Invitrogen IL-10 antibody (eBioscience, JES3-9D7) was used in blocking or activating experiments on African green monkey samples at 10 ug/ml (fig s4). Nat Med (2013) ncbi
mouse monoclonal (945A2A5)
  • immunohistochemistry - paraffin section; human; fig 2
In order to determine the effects of endurance training-induced weight loss, diet-induced weight loss, and endurance training per se (without weight loss) on plasma adiponectin and adipose tissue macrophage content in young, moderately overweight men, Invitrogen IL-10 antibody (Invitrogen, AHC9102) was used in immunohistochemistry - paraffin section on human samples (fig 2). Am J Physiol Regul Integr Comp Physiol (2013) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig 1
In order to determine cytokine profiles of CD4(+) T-helper (h) cells in adults and young children vaccinated with the antigens PspA, PcpA, PhtD, PhtE, Ply, LytB of Streptococcus pneumonia and protein D and OMP26 of non-typeable Haemophilus influenza, Invitrogen IL-10 antibody (Caltag, clone JES3-9D7) was used in flow cytometry on human samples (fig 1). Vaccine (2013) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human
In order to study if IFN-lambda has immunomodulatory effects in HCV- infected individuals, Invitrogen IL-10 antibody (Biosource, JES3-9D7) was used in blocking or activating experiments on human samples . PLoS ONE (2012) ncbi
rat monoclonal (JES3-9D7)
  • immunocytochemistry; human; 1 ug/ml; fig 3
In order to establish a microfluidic method to analyze single cell secretions, Invitrogen IL-10 antibody (Invitrogen, RHCIL1001) was used in immunocytochemistry on human samples at 1 ug/ml (fig 3). Biosens Bioelectron (2011) ncbi
mouse monoclonal (945A5A10)
  • ELISA; human; fig 3
In order to establish a microfluidic method to analyze single cell secretions, Invitrogen IL-10 antibody (Invitrogen, AHC7109) was used in ELISA on human samples (fig 3). Biosens Bioelectron (2011) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; rhesus macaque
  • flow cytometry; African green monkey; fig 3
In order to characterizes the systemic and local cell-mediated immune responses control granuloma growth in Leishmania braziliensis-infected maxaques, Invitrogen IL-10 antibody (Caltag, JES3-9D7) was used in flow cytometry on rhesus macaque samples and in flow cytometry on African green monkey samples (fig 3). Vet Immunol Immunopathol (2010) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig 3
In order to describe a 6-color assay to analyze peripheral blood dendritic cell responses upon whole blood stimulation, Invitrogen IL-10 antibody (Caltag, JES3-9D7) was used in flow cytometry on human samples (fig 3). J Immunol Methods (2008) ncbi
rat monoclonal (JES3-9D7)
  • immunohistochemistry; rhesus macaque
In order to examine links between SIV viral reservoir sites, CD8+ T-cell activation/death and outcome, Invitrogen IL-10 antibody (Biosource, JES3-9D7) was used in immunohistochemistry on rhesus macaque samples . Cell Death Differ (2007) ncbi
mouse monoclonal (945A5D11)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss if patients with Crohn's disease and orofacial granulomatosis should be considered as a unique subset, Invitrogen IL-10 antibody (BioSource, 945A5D11) was used in immunohistochemistry - paraffin section on human samples at 1:200. Inflamm Bowel Dis (2007) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human
In order to determine the presence and functional characteristics of T regulatory cells in colonic lymphoid tissues in patients with ulcerative colitis, Invitrogen IL-10 antibody (BioSource, JES3-9D7) was used in blocking or activating experiments on human samples . Inflamm Bowel Dis (2007) ncbi
rat monoclonal (JES3-9D7)
  • immunohistochemistry - paraffin section; human
In order to determine the in vivo distribution of Foxp3+CD4+CD25+ cells in mice that have recovered from colitis, Invitrogen IL-10 antibody (Caltag, JES3-9D7) was used in immunohistochemistry - paraffin section on human samples . J Immunol (2006) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human; 2.5 ul/10^6 cells
In order to assess the relationship between interleukin-10 promoter -1082 polymorphism and cell-mediated immune response during Chlamydia trachomatis infection, Invitrogen IL-10 antibody (Caltag, JES3-9D7) was used in blocking or activating experiments on human samples at 2.5 ul/10^6 cells. Genes Immun (2006) ncbi
mouse monoclonal (945A5D11)
  • ELISA; human; 1 ug/ml
In order to examine the effect of age and inflammation on the induction of Hsp27 in human peripheral blood mononuclear cells, Invitrogen IL-10 antibody (Biosource, 945A 5D11) was used in ELISA on human samples at 1 ug/ml. Exp Gerontol (2006) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human
In order to show that TGF-beta1 is involved in the suppressive activity of Leishmania guyanensis-stimulated CD4+ CD25+ T cells from healthy controls, Invitrogen IL-10 antibody (Biosource, JES3-9D7) was used in blocking or activating experiments on human samples . Infect Immun (2005) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig 2
In order to show that human rhinoviruses alters the accessory molecule repertoire of dendritic cells, Invitrogen IL-10 antibody (Caltag, JES3-9D7) was used in flow cytometry on human samples (fig 2). J Immunol (2005) ncbi
mouse monoclonal (945A5A10)
  • ELISA; human; fig 1
In order to assess antibodies used in IL-10 for enzyme-linked immunosorbent assay, Invitrogen IL-10 antibody (Biosource, . AHC7109) was used in ELISA on human samples (fig 1). J Immunol Methods (2005) ncbi
mouse monoclonal (945A5D11)
  • ELISA; human; 1 ug/ml; tbl 1
In order to explore the immunomodulatory effects of insulin-like growth factor through regulation of cytokine production, Invitrogen IL-10 antibody (Biosource, 945A5D11) was used in ELISA on human samples at 1 ug/ml (tbl 1). J Leukoc Biol (2004) ncbi
rat monoclonal (9D7)
  • flow cytometry; rhesus macaque
  • immunocytochemistry; rhesus macaque
In order to examine IL-12 and IL-10 production by neutrophils isolated from naive or measles virus-infected rhesus macaques, Invitrogen IL-10 antibody (BioSource, 9D7) was used in flow cytometry on rhesus macaque samples and in immunocytochemistry on rhesus macaque samples . Viral Immunol (2003) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig 5
In order to investigate the involvement of the PD-1 system in rheumatoid arthritis, Invitrogen IL-10 antibody (Caltag, JES3-9D7) was used in flow cytometry on human samples (fig 5). J Rheumatol (2003) ncbi
rat monoclonal (JES3-12G8)
  • ELISA; human; tbl 1
In order to compare the effect of different immunosuppressive regimens on cytokine expression in the grafted lung, Invitrogen IL-10 antibody (Endogen, 12G8) was used in ELISA on human samples (tbl 1). Transplant Proc (2003) ncbi
rat monoclonal (9D7)
  • ELISA; human; tbl 1
In order to compare the effect of different immunosuppressive regimens on cytokine expression in the grafted lung, Invitrogen IL-10 antibody (Endogen, 9D7) was used in ELISA on human samples (tbl 1). Transplant Proc (2003) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; 5 ug/ml; fig 1
In order to report an in vitro differentiation assay in which human naive CD4(+) cells are driven toward either the Th1 or Th2 phenotype and study them, Invitrogen IL-10 antibody (BioSource, JES3-9D7) was used in flow cytometry on human samples at 5 ug/ml (fig 1). J Immunol (2002) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
In order to characterize CD8 cells present in chronic hepatitis B virus, Invitrogen IL-10 antibody (Caltag, Jes3-9D7) was used in flow cytometry on human samples . J Exp Med (2002) ncbi
rat monoclonal (12G8)
  • ELISA; human; fig 1
In order to test if factors released from human alveolar macrophages exposed to air pollution particles accelerate the maturation of granulocyte precursors, Invitrogen IL-10 antibody (Endogen, M011B) was used in ELISA on human samples (fig 1). Exp Lung Res (2002) ncbi
rat monoclonal (9D7)
  • ELISA; human; fig 1
In order to test if factors released from human alveolar macrophages exposed to air pollution particles accelerate the maturation of granulocyte precursors, Invitrogen IL-10 antibody (Endogen, M010E) was used in ELISA on human samples (fig 1). Exp Lung Res (2002) ncbi
rat monoclonal (9D7)
  • flow cytometry; rhesus macaque
In order to investigate the role of IL-12 in measles induced immunosuppression, Invitrogen IL-10 antibody (BioSource International, clone 9D7) was used in flow cytometry on rhesus macaque samples . J Infect Dis (2002) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
In order to analyze the Th1/Th2 cytokine profile of intestinal samples from patients with inflammatory bowel disease, Invitrogen IL-10 antibody (Biosource, JES3-9D7) was used in flow cytometry on human samples . Clin Exp Immunol (2001) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
In order to measure cytokine production by intestinal T cells isolated from patients with spondyloarthropathy, Invitrogen IL-10 antibody (Biosource, JES3-9D7) was used in flow cytometry on human samples . Ann Rheum Dis (2001) ncbi
mouse monoclonal (945A5D11)
  • ELISA; human; fig 6
In order to compare the expression and response of TLRs on monocytes and dendritic cells, Invitrogen IL-10 antibody (Biosource, clones 945A5D11) was used in ELISA on human samples (fig 6). J Immunol (2000) ncbi
mouse monoclonal (945A5A10)
  • ELISA; African green monkey; 0.8 ug/ml; fig 2
In order to test if repeated exposure to Schistosoma mansoni stimulates hepatic fibrosis in olive baboons, Invitrogen IL-10 antibody (BioSource International, AHC7109) was used in ELISA on African green monkey samples at 0.8 ug/ml (fig 2). J Immunol (2000) ncbi
mouse monoclonal (945A5D11)
  • ELISA; African green monkey; 3 ug/ml; fig 2
In order to test if repeated exposure to Schistosoma mansoni stimulates hepatic fibrosis in olive baboons, Invitrogen IL-10 antibody (BioSource International, AHC8102) was used in ELISA on African green monkey samples at 3 ug/ml (fig 2). J Immunol (2000) ncbi
mouse monoclonal (945A5D11)
  • ELISA; human
In order to determine the ability of chemoattractants to affect IL-12 production by human monocytes and dendritic cells, Invitrogen IL-10 antibody (BioSource, AHC8102) was used in ELISA on human samples . J Immunol (2000) ncbi
mouse monoclonal (945A5A10)
  • ELISA; human
In order to determine the ability of chemoattractants to affect IL-12 production by human monocytes and dendritic cells, Invitrogen IL-10 antibody (BioSource, AHC7109) was used in ELISA on human samples . J Immunol (2000) ncbi
mouse monoclonal (945A5A10)
  • ELISA; baboon ; 0.8 ug/ml
In order to test if variations in exposure and treatment contribute to the heterogeneity in immunity and granuloma-induced pathology in schistosomiasis, Invitrogen IL-10 antibody (Biosource, AHC7109) was used in ELISA on baboon samples at 0.8 ug/ml. Infect Immun (1999) ncbi
mouse monoclonal (945A5D11)
  • ELISA; baboon ; 3 ug/ml
In order to test if variations in exposure and treatment contribute to the heterogeneity in immunity and granuloma-induced pathology in schistosomiasis, Invitrogen IL-10 antibody (Biosource, AHC8102) was used in ELISA on baboon samples at 3 ug/ml. Infect Immun (1999) ncbi
mouse monoclonal (945A5A10)
  • ELISA; rhesus macaque; fig 5
In order to use rhIL-12 and alum as adjuvants in primate model of cutaneous leishmaniasis to test if the killed pathogen is a sufficient to generate protective antibodies, Invitrogen IL-10 antibody (Biosource, 945A5A10) was used in ELISA on rhesus macaque samples (fig 5). J Immunol (1999) ncbi
mouse monoclonal (945A5D11)
  • ELISA; rhesus macaque; fig 5
In order to use rhIL-12 and alum as adjuvants in primate model of cutaneous leishmaniasis to test if the killed pathogen is a sufficient to generate protective antibodies, Invitrogen IL-10 antibody (Biosource, 945A5D11) was used in ELISA on rhesus macaque samples (fig 5). J Immunol (1999) ncbi
rat monoclonal (JES3-9D7)
  • ELISA; human; fig 4
In order to elucidate the mechanism of TNF-alpha-augmented mucosal T cell IFN-gamma production, Invitrogen IL-10 antibody (Biosource, JES3-9D7) was used in ELISA on human samples (fig 4). J Immunol (1999) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig 2
In order to measure cytokines after head injury, Invitrogen IL-10 antibody (Caltag, JES3-9D7) was used in flow cytometry on human samples (fig 2). Shock (1999) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
In order to elucidate the role of A2ARs in the regulation of immune response, Invitrogen IL-10 antibody (Caltag, JES3?C9D7) was used in flow cytometry on human samples . Mol Pharmacol (1999) ncbi
mouse monoclonal (945A5D11)
  • ELISA; human
In order to show that cholera toxin inhibits the production of interleukin-12, Invitrogen IL-10 antibody (Biosource, AHC8102) was used in ELISA on human samples . J Exp Med (1999) ncbi
mouse monoclonal (945A5A10)
  • ELISA; human
In order to show that cholera toxin inhibits the production of interleukin-12, Invitrogen IL-10 antibody (Biosource, AHC7109) was used in ELISA on human samples . J Exp Med (1999) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human
In order to determine the roles of immune complexes in HCV-specific cytotoxic T lymphocyte induction, Invitrogen IL-10 antibody (Biosource, JES3-9D7) was used in blocking or activating experiments on human samples . Immunology (1998) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human
In order to examine the effect of immune complexes on interleukin-12 secretion by human monocytes, Invitrogen IL-10 antibody (Biosource, JES3-9D7) was used in blocking or activating experiments on human samples . Eur J Immunol (1997) ncbi
rat monoclonal (JES3-9D7)
  • ELISA; human
In order to use lymphokines to identify subsets of human T cells, Invitrogen IL-10 antibody (noco, noca) was used in ELISA on human samples . Science (1991) ncbi
rat monoclonal (JES3-12G8)
  • ELISA; human; fig 1
In order to study IL-10 in the peritoneal cavity of ovarian cancer bearing patients, Invitrogen IL-10 antibody (noco, JES3-12G8) was used in ELISA on human samples (fig 1). Cytokine (1992) ncbi
rat monoclonal (JES3-9D7)
  • ELISA; human; fig 1
In order to assess whether human IL-10 is produced by activated Th0, Th1-, and Th2-like CD4+ T cell clones, Invitrogen IL-10 antibody (noco, noca) was used in ELISA on human samples (fig 1). J Immunol (1992) ncbi
BioLegend
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...
BioLegend IL-10 antibody (Biolegend, JES3-9D7) was used in flow cytometry on human samples . Arthritis Res Ther (2021) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 1b
BioLegend IL-10 antibody (BioLegend, JES3-9D7) was used in flow cytometry on human samples (fig 1b). J Immunol (2019) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 1e
BioLegend IL-10 antibody (BioLegend, 501426) was used in flow cytometry on human samples (fig 1e). Cell (2019) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig s6c
BioLegend IL-10 antibody (BioLegend, JES3-9D7) was used in flow cytometry on human samples (fig s6c). Leukemia (2019) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 4a
BioLegend IL-10 antibody (BioLegend, JES3-9D7) was used in flow cytometry on human samples (fig 4a). J Exp Med (2018) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human; 100 ug/ml; loading ...; fig 7a
BioLegend IL-10 antibody (BioLegend, JES3-9D7) was used in blocking or activating experiments on human samples at 100 ug/ml (fig 7a). Am J Trop Med Hyg (2018) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig 4c
BioLegend IL-10 antibody (Biolegend, JES3-9D7) was used in flow cytometry on human samples (fig 4c). Front Immunol (2017) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 2a
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend IL-10 antibody (Biolegend, 501420) was used in flow cytometry on human samples (fig 2a). Cell Death Dis (2017) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human; loading ...; fig 3d
BioLegend IL-10 antibody (Biolegend, JES3-19F1) was used in flow cytometry on human samples (fig 3d). Ann Rheum Dis (2018) ncbi
rat monoclonal (JES3-9D7)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend IL-10 antibody (BioLegend, JES3-9D7) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend IL-10 antibody (BioLegend, 501404) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 2c
BioLegend IL-10 antibody (BioLegend, JES3-9D7) was used in flow cytometry on human samples (fig 2c). Cell Death Dis (2016) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; black flying fox; loading ...; fig 6b
In order to describe the phenotypic and functional characterization of T cell subsets, B and NK cells in the fruit-eating bat Pteropus alecto, BioLegend IL-10 antibody (Biolegend, JES3-19F1) was used in flow cytometry on black flying fox samples (fig 6b). Sci Rep (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig s2b
In order to evaluate combinations of TLR and C-type lectin receptor agonists on the Th1 responses of newborn dendritic cells, BioLegend IL-10 antibody (BioLegend, JES3-9D7) was used in flow cytometry on human samples (fig s2b). J Immunol (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 5d
BioLegend IL-10 antibody (Biolegend, 501410) was used in flow cytometry on human samples (fig 5d). Cell (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig 2
BioLegend IL-10 antibody (Biolegend, JES3-9D7) was used in flow cytometry on human samples (fig 2). PLoS Pathog (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; fig s5h
BioLegend IL-10 antibody (Biolegend, JES3-9D7) was used in flow cytometry on human samples (fig s5h). Eur J Immunol (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IL-10 antibody (Biolegend, JE53-9D7) was used in flow cytometry on human samples (fig 2a). PLoS Pathog (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 8b
In order to perform an antigenic analysis of Bla g 2 using antibodies, BioLegend IL-10 antibody (Biolegend, JES3-9D7) was used in flow cytometry on human samples (fig 8b). J Biol Chem (2016) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human; 1 ug/ml; loading ...
BioLegend IL-10 antibody (BioLegend, JES3-9D7) was used in blocking or activating experiments on human samples at 1 ug/ml. Sci Transl Med (2015) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human; fig 4
BioLegend IL-10 antibody (Biolegend, JES3-9D7) was used in blocking or activating experiments on human samples (fig 4). PLoS Pathog (2015) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
BioLegend IL-10 antibody (Biolegend, 50141) was used in flow cytometry on human samples . Scand J Med Sci Sports (2016) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BioLegend IL-10 antibody (Biolegend, clone JES3-9D7) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human
BioLegend IL-10 antibody (Biolegend, 506804) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; 5 ul/test
In order to analyze mucosal pinch biopsies collected predominantly during colonoscopies, BioLegend IL-10 antibody (Biolegend, JES3-9D7) was used in flow cytometry on human samples at 5 ul/test. J Immunol Methods (2015) ncbi
rat monoclonal (JES3-9D7)
  • dot blot; human; tbl s1
In order to use polydimethylsiloxane microchambers to co-detect 42 immune effector proteins secreted from a single LPS-stimulation macrophage, BioLegend IL-10 antibody (Biolegend, 501402) was used in dot blot on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
rat monoclonal (JES3-12G8)
  • dot blot; human; tbl s1
In order to use polydimethylsiloxane microchambers to co-detect 42 immune effector proteins secreted from a single LPS-stimulation macrophage, BioLegend IL-10 antibody (Biolegend, 501504) was used in dot blot on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
rat monoclonal (JES3-9D7)
  • blocking or activating experiments; human
BioLegend IL-10 antibody (BioLegend, JES3-9D7) was used in blocking or activating experiments on human samples . J Immunol (2015) ncbi
rat monoclonal (JES3-19F1)
BioLegend IL-10 antibody (Biolegend, JES3-19F1) was used . PLoS ONE (2014) ncbi
rat monoclonal (JES3-19F1)
In order to investigate the progression of innate responses to mycobacteria in infants, BioLegend IL-10 antibody (Biolegend, JES3-19F1) was used . J Immunol (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (E-10)
  • western blot; human; fig 3
Santa Cruz Biotechnology IL-10 antibody (Santa Cruz, sc-8438) was used in western blot on human samples (fig 3). BMC Med Genomics (2015) ncbi
mouse monoclonal (E-10)
  • immunocytochemistry; human; fig 3d
  • western blot; human; 1:500; fig 3n
Santa Cruz Biotechnology IL-10 antibody (Santa Cruz Biotechnology, sc-8438) was used in immunocytochemistry on human samples (fig 3d) and in western blot on human samples at 1:500 (fig 3n). Eur J Immunol (2016) ncbi
mouse monoclonal (E-10)
  • immunohistochemistry; human; loading ...; fig 2d
In order to study the effect of topical tenofovir gel in the rectal mucosa and primary vaginal cells., Santa Cruz Biotechnology IL-10 antibody (Santa Cruz Biotechnology, sc-8438) was used in immunohistochemistry on human samples (fig 2d). elife (2015) ncbi
Abnova
mouse monoclonal (1C10)
  • western blot; human
Abnova IL-10 antibody (Abnova, 1C10) was used in western blot on human samples . Clin Exp Immunol (2014) ncbi
Abcam
mouse monoclonal (4A7-25-17)
  • western blot; mouse; 1:500; fig 4
Abcam IL-10 antibody (Abcam, ab134742) was used in western blot on mouse samples at 1:500 (fig 4). Int J Mol Med (2016) ncbi
BD Biosciences
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 8d
BD Biosciences IL-10 antibody (BD Biosciences, JES3-9D7) was used in flow cytometry on human samples (fig 8d). J Clin Invest (2022) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences IL-10 antibody (BD Biosciences, 554498) was used in flow cytometry on human samples (tbl 1). J Clin Invest (2018) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human; loading ...; fig s6
BD Biosciences IL-10 antibody (BD Biosciences, JES3-19F1) was used in flow cytometry on human samples (fig s6). Eur J Immunol (2018) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; African green monkey; fig s4b
In order to optimize the dosing regimen of neutralizing anti-HIV-1 antibodies, BD Biosciences IL-10 antibody (BD Biosciences, JES3-9D7) was used in flow cytometry on African green monkey samples (fig s4b). Nature (2017) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; loading ...; fig 3a
In order to establish the T Cell receptor-inducible costimulator as a promising target for direct T regulatory cell-targeting therapeutic agents for gastric cancer, BD Biosciences IL-10 antibody (BD Biosciences, JES3-9D7) was used in flow cytometry on human samples (fig 3a). Int J Cancer (2017) ncbi
rat monoclonal (JES3-12G8)
  • ELISA; human; loading ...; fig 1
In order to test if soluble CTLA-4 controls autoantigen-specific immunity in a model of systemic lupus erythematosus, BD Biosciences IL-10 antibody (BD Biosciences, JES3-12G8) was used in ELISA on human samples (fig 1). Arthritis Res Ther (2016) ncbi
rat monoclonal (JES3-19F1)
  • ELISA; human; loading ...; fig 1
In order to test if soluble CTLA-4 controls autoantigen-specific immunity in a model of systemic lupus erythematosus, BD Biosciences IL-10 antibody (BD Biosciences, JES3-19 F1) was used in ELISA on human samples (fig 1). Arthritis Res Ther (2016) ncbi
rat monoclonal (JES3-12G8)
  • immunohistochemistry - frozen section; human
BD Biosciences IL-10 antibody (BD Biosciences Pharmingen, JES3-12G8) was used in immunohistochemistry - frozen section on human samples . Tech Coloproctol (2016) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human; fig 6
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, BD Biosciences IL-10 antibody (BD Biosciences, JES3-19F1) was used in flow cytometry on human samples (fig 6). J Transl Med (2016) ncbi
rat monoclonal (JES3-19F1)
  • ELISA; human; loading ...; fig 4a
In order to examine the contribution of T cells to myasthenia gravis, BD Biosciences IL-10 antibody (BD Biosciences, JES3-19F1) was used in ELISA on human samples (fig 4a). J Immunol (2016) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human; loading ...; fig 4e
In order to examine if pregnancy-related changes in disease activity are associated with changes in T cell populations, BD Biosciences IL-10 antibody (BD Biosciences, JES3-19 F1) was used in flow cytometry on human samples (fig 4e). Arthritis Res Ther (2016) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences IL-10 antibody (BD Pharmingen, JES3-19F1) was used in flow cytometry on human samples (fig 3d). PLoS ONE (2016) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences IL-10 antibody (BD Biosciences, JEF3-19F1) was used in flow cytometry on human samples (fig s1). Sci Transl Med (2015) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human; loading ...; fig 4c
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, BD Biosciences IL-10 antibody (BD-PharMingen, 554707) was used in flow cytometry on human samples (fig 4c). Hum Vaccin Immunother (2016) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human; fig 4
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BD Biosciences IL-10 antibody (BD Biosciences, JES3-19F1) was used in flow cytometry on human samples (fig 4). Mucosal Immunol (2016) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human; 6:100; fig 3a
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, BD Biosciences IL-10 antibody (Becton Dickinson, JES3-19F1) was used in flow cytometry on human samples at 6:100 (fig 3a). Nat Commun (2015) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human; 5 ug/ml; fig 3
BD Biosciences IL-10 antibody (BD Biosciences, JES3-9D7) was used in flow cytometry on human samples at 5 ug/ml (fig 3). J Autoimmun (2015) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human; fig 1
BD Biosciences IL-10 antibody (BD Pharmingen, JES3-19F1) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
rat monoclonal (JES3-19F1)
  • blocking or activating experiments; human; loading ...; fig 5b
In order to determine the role of IL-10 produced by T regulatory cells in patients with immune thrombocytopenia, BD Biosciences IL-10 antibody (BD Bioscience, 554703) was used in blocking or activating experiments on human samples (fig 5b). Immunol Res (2015) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BD Biosciences IL-10 antibody (BD Pharmingen, clone JES3-9D7) was used in flow cytometry on human samples . Chest (2015) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, BD Biosciences IL-10 antibody (BD, JES3-19F1) was used in flow cytometry on human samples . Nat Immunol (2015) ncbi
rat monoclonal (JES3-12G8)
  • ELISA; human; 1:1000
BD Biosciences IL-10 antibody (BD Pharmingen, JES3-12G8) was used in ELISA on human samples at 1:1000. Nat Commun (2014) ncbi
rat monoclonal (JES3-9D7)
  • ELISA; human; 1:1000
BD Biosciences IL-10 antibody (BD Pharmingen, JES3-9D7) was used in ELISA on human samples at 1:1000. Nat Commun (2014) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; human
BD Biosciences IL-10 antibody (BD Biosciences, JES3-19F1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
rat monoclonal (JES3-19F1)
  • flow cytometry; rat; fig 6
BD Biosciences IL-10 antibody (BD Biosciences, JES3-19F1) was used in flow cytometry on rat samples (fig 6). Eur J Immunol (2015) ncbi
rat monoclonal (JES3-9D7)
  • flow cytometry; human
BD Biosciences IL-10 antibody (BD Bioscience, JES3-9D7) was used in flow cytometry on human samples . Immunology (2015) ncbi
rat monoclonal (JES3-12G8)
  • ELISA; human
In order to determine the immunomodulator activity of Ixodes ricinus immunosuppressor (Iris), BD Biosciences IL-10 antibody (PharMingen, JES3-12G8) was used in ELISA on human samples . J Biol Chem (2002) ncbi
rat monoclonal (JES3-9D7)
  • ELISA; human
In order to determine the immunomodulator activity of Ixodes ricinus immunosuppressor (Iris), BD Biosciences IL-10 antibody (PharMingen, JES3-9D) was used in ELISA on human samples . J Biol Chem (2002) ncbi
Articles Reviewed
  1. Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer. 2022;10: pubmed publisher
  2. Besnard M, S xe9 razin C, Ossart J, Moreau A, Vimond N, Flippe L, et al. Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J Clin Invest. 2022;132: pubmed publisher
  3. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed publisher
  4. Jeong J, Choi S, Ahn S, Oh J, Kim Y, Lee C, et al. Neutrophil extracellular trap clearance by synovial macrophages in gout. Arthritis Res Ther. 2021;23:88 pubmed publisher
  5. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed publisher
  6. Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell D, et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 2019;177:1583-1599.e16 pubmed publisher
  7. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed publisher
  8. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  9. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed publisher
  10. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed publisher
  11. Imbrechts M, De Samblancx K, Fierens K, Brisse E, Vandenhaute J, Mitera T, et al. IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways. Eur J Immunol. 2018;48:1506-1521 pubmed publisher
  12. Sayin I, Radtke A, Vella L, Jin W, Wherry E, Buggert M, et al. Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med. 2018;215:1531-1542 pubmed publisher
  13. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed publisher
  14. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed publisher
  15. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  16. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed publisher
  17. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  18. Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63-69 pubmed publisher
  19. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  20. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed publisher
  21. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  22. Wei C, Mei J, Tang L, Liu Y, Li D, Li M, et al. 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis. Cell Death Dis. 2016;7:e2489 pubmed publisher
  23. Martínez Gómez J, Periasamy P, Dutertre C, Irving A, Ng J, Crameri G, et al. Phenotypic and functional characterization of the major lymphocyte populations in the fruit-eating bat Pteropus alecto. Sci Rep. 2016;6:37796 pubmed publisher
  24. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  25. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  26. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed publisher
  27. Miles B, Miller S, Folkvord J, Levy D, Rakasz E, Skinner P, et al. Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection. PLoS Pathog. 2016;12:e1005924 pubmed publisher
  28. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed publisher
  29. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  30. Dahal L, Basu N, Youssef H, Khanolkar R, Barker R, Erwig L, et al. Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus. Arthritis Res Ther. 2016;18:180 pubmed publisher
  31. Hou C, Wu Q, Ouyang C, Huang T. Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines. Int J Mol Med. 2016;38:713-20 pubmed publisher
  32. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed publisher
  33. van Onkelen R, Gosselink M, Van Meurs M, Melief M, Schouten W, Laman J. Pro-inflammatory cytokines in cryptoglandular anal fistulas. Tech Coloproctol. 2016;20:619-25 pubmed publisher
  34. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  35. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  36. Chu H, Khosravi A, Kusumawardhani I, Kwon A, Vasconcelos A, Cunha L, et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science. 2016;352:1116-20 pubmed publisher
  37. Roth S, Spalinger M, Gottier C, Biedermann L, Zeitz J, Lang S, et al. Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis. PLoS ONE. 2016;11:e0154817 pubmed publisher
  38. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed publisher
  39. Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, O Connor K. Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production. J Immunol. 2016;196:2075-84 pubmed publisher
  40. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  41. Tham M, Schlör G, Yerly D, Mueller C, Surbek D, Villiger P, et al. Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis. Arthritis Res Ther. 2016;18:26 pubmed publisher
  42. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  43. Woodfolk J, Glesner J, Wright P, Kepley C, Li M, Himly M, et al. Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem. 2016;291:2288-301 pubmed publisher
  44. Venza I, Visalli M, Beninati C, Benfatto S, Teti D, Venza M. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma. BMC Med Genomics. 2015;8:81 pubmed publisher
  45. Schminke B, Trautmann S, Mai B, Miosge N, Blaschke S. Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage. Eur J Immunol. 2016;46:440-5 pubmed publisher
  46. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed publisher
  47. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed publisher
  48. Scottà C, Fanelli G, Hoong S, Romano M, Lamperti E, Sukthankar M, et al. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica. 2016;101:91-100 pubmed publisher
  49. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed publisher
  50. Gulati N, Suárez Fariñas M, Correa Da Rosa J, Krueger J. Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions. F1000Res. 2015;4:149 pubmed publisher
  51. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  52. Rancan C, Schirrmann L, Hüls C, Zeidler R, Moosmann A. Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells. PLoS Pathog. 2015;11:e1004906 pubmed publisher
  53. van de Vyver M, Engelbrecht L, Smith C, Myburgh K. Neutrophil and monocyte responses to downhill running: Intracellular contents of MPO, IL-6, IL-10, pstat3, and SOCS3. Scand J Med Sci Sports. 2016;26:638-47 pubmed publisher
  54. Prata T, Bonin C, Ferreira A, Padovani C, Fernandes C, Machado A, et al. Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions. Immunology. 2015;146:113-21 pubmed publisher
  55. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  56. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed publisher
  57. Riccio E, Pratt Riccio L, Bianco Júnior C, Sanchez V, Totino P, Carvalho L, et al. Molecular and immunological tools for the evaluation of the cellular immune response in the neotropical monkey Saimiri sciureus, a non-human primate model for malaria research. Malar J. 2015;14:166 pubmed publisher
  58. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed publisher
  59. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  60. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed publisher
  61. Nouël A, Pochard P, Simon Q, Ségalen I, Le Meur Y, Pers J, et al. B-Cells induce regulatory T cells through TGF-β/IDO production in A CTLA-4 dependent manner. J Autoimmun. 2015;59:53-60 pubmed publisher
  62. Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, et al. Mucosal effects of tenofovir 1% gel. elife. 2015;4: pubmed publisher
  63. Lu Y, Xue Q, Eisele M, Sulistijo E, Brower K, Han L, et al. Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands. Proc Natl Acad Sci U S A. 2015;112:E607-15 pubmed publisher
  64. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  65. Li F, Ji L, Wang W, Hua F, Zhan Y, Zou S, et al. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res. 2015;61:269-80 pubmed publisher
  66. Hatano R, Ohnuma K, Otsuka H, Komiya E, Taki I, Iwata S, et al. CD26-mediated induction of EGR2 and IL-10 as potential regulatory mechanism for CD26 costimulatory pathway. J Immunol. 2015;194:960-72 pubmed publisher
  67. Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D. IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease. Autoimmun Rev. 2015;14:370-5 pubmed publisher
  68. Cousens L, Najafian N, Martin W, De Groot A. Tregitope: Immunomodulation powerhouse. Hum Immunol. 2014;75:1139-46 pubmed publisher
  69. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  70. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed publisher
  71. Vogelpoel L, Hansen I, Rispens T, Muller F, van Capel T, Turina M, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444 pubmed publisher
  72. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed publisher
  73. Mohanty S, Joshi S, Ueda I, Wilson J, Blevins T, Siconolfi B, et al. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis. 2015;211:1174-84 pubmed publisher
  74. Xie L, Choudhury G, Winters A, Yang S, Jin K. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol. 2015;45:180-91 pubmed publisher
  75. Preciado Llanes L, Wing J, Foster R, Carlring J, Lees A, Read R, et al. Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linking. Immunology. 2014;: pubmed publisher
  76. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed publisher
  77. Kyriakidis N, Kapsogeorgou E, Gourzi V, Konsta O, Baltatzis G, Tzioufas A. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway. Clin Exp Immunol. 2014;178:548-60 pubmed publisher
  78. Said A, Bock S, Müller G, Weindl G. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro. Immunology. 2015;144:218-30 pubmed publisher
  79. Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed publisher
  80. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed publisher
  81. Auerbach P, Nordby P, Bendtsen L, Mehlsen J, Basnet S, Vestergaard H, et al. Differential effects of endurance training and weight loss on plasma adiponectin multimers and adipose tissue macrophages in younger, moderately overweight men. Am J Physiol Regul Integr Comp Physiol. 2013;305:R490-8 pubmed publisher
  82. Sharma S, Roumanes D, Almudevar A, Mosmann T, Pichichero M. CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens. Vaccine. 2013;31:3090-7 pubmed publisher
  83. Dolganiuc A, Kodys K, Marshall C, Saha B, Zhang S, Bala S, et al. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells. PLoS ONE. 2012;7:e44915 pubmed publisher
  84. Konry T, Dominguez Villar M, Baecher Allan C, Hafler D, Yarmush M. Droplet-based microfluidic platforms for single T cell secretion analysis of IL-10 cytokine. Biosens Bioelectron. 2011;26:2707-10 pubmed publisher
  85. de Campos S, Souza Lemos C, Teva A, Porrozzi R, Grimaldi G. Systemic and compartmentalised immune responses in a Leishmania braziliensis-macaque model of self-healing cutaneous leishmaniasis. Vet Immunol Immunopathol. 2010;137:149-54 pubmed publisher
  86. Della Bella S, Giannelli S, Taddeo A, Presicce P, Villa M. Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays. J Immunol Methods. 2008;339:153-64 pubmed publisher
  87. Cumont M, Monceaux V, Viollet L, Lay S, Parker R, Hurtrel B, et al. TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ. 2007;14:1747-58 pubmed publisher
  88. Freysdottir J, Zhang S, Tilakaratne W, Fortune F. Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment. Inflamm Bowel Dis. 2007;13:439-45 pubmed
  89. Yu Q, Saruta M, Avanesyan A, Fleshner P, Banham A, Papadakis K. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis. 2007;13:191-9 pubmed
  90. Uhlig H, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol. 2006;177:5852-60 pubmed
  91. Ohman H, Tiitinen A, Halttunen M, Birkelund S, Christiansen G, Koskela P, et al. IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis. Genes Immun. 2006;7:243-9 pubmed
  92. Njemini R, Lambert M, Demanet C, Mets T. The effect of aging and inflammation on heat shock protein 27 in human monocytes and lymphocytes. Exp Gerontol. 2006;41:312-9 pubmed
  93. Kariminia A, Bourreau E, Pascalis H, Couppie P, Sainte Marie D, Tacchini Cottier F, et al. Transforming growth factor beta 1 production by CD4+ CD25+ regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis. Infect Immun. 2005;73:5908-14 pubmed
  94. Kirchberger S, Majdic O, Steinberger P, Bluml S, Pfistershammer K, Zlabinger G, et al. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol. 2005;175:1145-52 pubmed
  95. Thom F, Stockhausen H, Germann T, Frosch S, Wade E. Biological inactivation and impaired detection of IL-10 by suramin. J Immunol Methods. 2005;299:91-8 pubmed
  96. Kooijman R, Coppens A. Insulin-like growth factor-I stimulates IL-10 production in human T cells. J Leukoc Biol. 2004;76:862-7 pubmed
  97. Hoffman S, Polack F, Hauer D, Griffin D. Measles virus infection of rhesus macaques affects neutrophil expression of IL-12 and IL-10. Viral Immunol. 2003;16:369-79 pubmed
  98. Hatachi S, Iwai Y, Kawano S, Morinobu S, Kobayashi M, Koshiba M, et al. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol. 2003;30:1410-9 pubmed
  99. Meloni F, Cascina A, Paschetto E, Marone Bianco A, Morosini M, Pellegrini C, et al. Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. Transplant Proc. 2003;35:1523-6 pubmed
  100. Cousins D, Lee T, Staynov D. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol. 2002;169:2498-506 pubmed
  101. Reignat S, Webster G, Brown D, Ogg G, King A, Seneviratne S, et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med. 2002;195:1089-101 pubmed
  102. Leboulle G, Crippa M, Decrem Y, Mejri N, Brossard M, Bollen A, et al. Characterization of a novel salivary immunosuppressive protein from Ixodes ricinus ticks. J Biol Chem. 2002;277:10083-9 pubmed
  103. Suwa T, Hogg J, Vincent R, Mukae H, Fujii T, van Eeden S. Ambient air particulates stimulate alveolar macrophages of smokers to promote differentiation of myeloid precursor cells. Exp Lung Res. 2002;28:1-18 pubmed
  104. Polack F, Hoffman S, Moss W, Griffin D. Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles. J Infect Dis. 2002;185:13-9 pubmed
  105. Van Damme N, De Keyser F, Demetter P, Baeten D, Mielants H, Verbruggen G, et al. The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome. Clin Exp Immunol. 2001;125:383-90 pubmed
  106. Van Damme N, De Vos M, Baeten D, Demetter P, Mielants H, Verbruggen G, et al. Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy. Ann Rheum Dis. 2001;60:495-9 pubmed
  107. Thoma Uszynski S, Kiertscher S, Ochoa M, Bouis D, Norgard M, Miyake K, et al. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol. 2000;165:3804-10 pubmed
  108. Farah I, Mola P, Kariuki T, Nyindo M, Blanton R, King C. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4. J Immunol. 2000;164:5337-43 pubmed
  109. Braun M, Lahey E, Kelsall B. Selective suppression of IL-12 production by chemoattractants. J Immunol. 2000;164:3009-17 pubmed
  110. Mola P, Farah I, Kariuki T, Nyindo M, Blanton R, King C. Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment. Infect Immun. 1999;67:6565-71 pubmed
  111. Kenney R, Sacks D, Sypek J, Vilela L, Gam A, Evans Davis K. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J Immunol. 1999;163:4481-8 pubmed
  112. Prehn J, Landers C, Targan S. A soluble factor produced by lamina propria mononuclear cells is required for TNF-alpha enhancement of IFN-gamma production by T cells. J Immunol. 1999;163:4277-83 pubmed
  113. Shimonkevitz R, Bar Or D, Harris L, Dole K, McLaughlin L, Yukl R. Transient monocyte release of interleukin-10 in response to traumatic brain injury. Shock. 1999;12:10-6 pubmed
  114. Koshiba M, Rosin D, Hayashi N, Linden J, Sitkovsky M. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol. 1999;55:614-24 pubmed
  115. Braun M, He J, Wu C, Kelsall B. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J Exp Med. 1999;189:541-52 pubmed
  116. Kanto T, Hayashi N, Takehara T, Katayama K, Ito A, Mochizuki K, et al. Cross-linking of Fc(gamma)-receptor on monocytes inhibits hepatitis C virus-specific cytotoxic T-lymphocyte induction in vitro. Immunology. 1998;94:461-8 pubmed
  117. Berger S, Chandra R, Ballo H, Hildenbrand R, Stutte H. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur J Immunol. 1997;27:2994-3000 pubmed
  118. Salgame P, Abrams J, Clayberger C, Goldstein H, Convit J, Modlin R, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 1991;254:279-82 pubmed
  119. Gotlieb W, Abrams J, Watson J, Velu T, Berek J, Martínez Maza O. Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine. 1992;4:385-90 pubmed
  120. Yssel H, de Waal Malefyt R, Roncarolo M, Abrams J, Lahesmaa R, Spits H, et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol. 1992;149:2378-84 pubmed